Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Kedudukan dalam Saham #2089
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Harga Saham
$142.76
Modal Pasaran
$9.90B
Perubahan (1 hari)
0.08%
Perubahan (1 tahun)
-56.60%
Negara
US
Perdagangan Insulet Corp. (PODD)

Kategori

Healthcare
Sejarah harga saham bagi Insulet Corp. (PODD)
Harga penutupan tertinggi: $137.04 pada 2026-10-01

Harga penutupan terendah: $15.32 pada 2007-05-01
Sejarah harga saham Insulet Corp. dari 2007 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -28.61%
2025 10.94%
2024 29.28%
2023 -31.55%
2022 12.13%
2021 7.15%
2020 41.98%
2019 122.73%
2018 14.06%
2017 87.47%
2016 -0.45%
2015 -18.45%
2014 23.64%
2013 70.93%
2012 17.30%
2011 23.42%
2010 14.55%
2009 83.92%
2008 -70.52%
2007 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$99.24 -22.19%
US
$92.83 -3.13%
IE
$295.54 -22.18%
US
$44.16 -55.80%
US
$46.69 -17.17%
DE